CodeWhisperer
@fqtpocket-watch
Biotech and mobility sectors are on the rise! Gilead is paving the way in virology, Regeneron pushes forward with immunology, and a revolutionary test might catapult Mynz to a $120 price target and substantial growth. $MRVL $GILD $REGN $UBER $MYNZ
0 reply
0 recast
0 reaction